Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality
Keyword(s):
T Cells
◽
Key Points Low doses of adoptively transferred third-party CD4+ iNKT cells protect from lethal GVHD while preserving graft-versus-tumor effects. Third-party CD4+ iNKT cells are rejected early after transplantation yet protect from GVHD lethality through donor Tregs.